TUESDAY, June 25, 2024 -- An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients,...
Vous n'êtes pas connecté
A recent study conducted by the WifOR Institute has shed light on the significant benefits of early and intensified treatment strategies for Type 2 diabetes (T2DM) patients in Korea. According to the study, which analyzed data over a ten-year period, patients who began combination therapy early in the course of their illness were 12% more […]
TUESDAY, June 25, 2024 -- An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients,...
A new study from the Karolinska Institutet, published in the journal eClinicalMedicine, reveals that GLP-1 agonists, a type of medication used to...
Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...
Insulet (PODD) reports positive findings from the SECURE-T2D pivotal trial, the largest study of AID therapy in people with type 2 diabetes.
A new study has found a surprising link between light behaviours and type 2 diabetes.
A new study has found a surprising link between light behaviours and type 2 diabetes.
A new study has found a surprising link between light behaviours and type 2 diabetes.
Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.
The recent cyberattacks affecting water treatment plants and systems across the nation shed light on the need for cybersecurity measures that...
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...